Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 21.11% vs -52.55% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 44.30% vs -68.62% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 44.12% vs -67.76% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -40.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Concord Biotech With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 21.11% vs -52.55% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -20.35% vs 18.23% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 44.30% vs -68.62% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -33.59% vs 18.17% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 44.12% vs -67.76% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -35.25% vs 14.66% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -40.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -40.00% vs -88.10% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






